Ptc Therapeutics (PTCT) Intangibles (2017 - 2026)

Ptc Therapeutics' Intangibles history runs 10 years deep, the most recent figure standing at $380.7 million for Q1 2026.

• On a quarterly basis, Intangibles rose 221.39% year-over-year to $380.7 million in Q1 2026; TTM through Mar 2026 was $380.7 million, a 221.39% increase from a year earlier, with the FY2025 full-year figure at $388.8 million, changed N/A from the prior year.
• Intangibles slipped to $380.7 million in Q1 2026 per PTCT's latest filing, from $388.8 million in the prior quarter.
• Across five years, Intangibles topped out at $763.7 million in Q1 2022 and bottomed at $118.4 million in Q1 2025.
• The 5-year median for Intangibles is $392.6 million (2025), against an average of $458.7 million.
• Across the five-year window, Intangibles slumped 64.11% in 2025 and soared 221.39% in 2026, its largest moves.
• Year by year, Intangibles stood at $705.9 million in 2022, then slumped by 46.24% to $379.5 million in 2023, then decreased by 12.95% to $330.4 million in 2024, then increased by 17.67% to $388.8 million in 2025, then declined by 2.08% to $380.7 million in 2026.
• Per Business Quant, the three latest PTCT Intangibles figures stand at $380.7 million (Q1 2026), $388.8 million (Q4 2025), and $396.5 million (Q3 2025).